The Valley Desk

NCT07450859 · Interventional trial

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Overall registry status Recruiting

Phase 2

Conditions Pancreatic Ductal Adenocarcinoma (PDAC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov